Parallel Advisors »

Quince Therapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Quince Therapeutics shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Quince Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Quince Therapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quince Therapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $81 795 0.10

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Corcept Therapeutics Stock (CORT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Microsoft Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Amazon.com Stock (AMZN)
Avantis International Equity Etf Etf (AVDE)
Cvb Finl Corp Stock (CVBF)
Vanguard Large Cap Etf (VV)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Victoryshares Free Cash Flow Etf Etf (VFLO)

View all positions for Parallel Advisors

Top funds holding Quince Therapeutics

Tudor Investment Corporation
Gen-Wealth Partners
Catalyst Funds Management Pty
Fortitude Family Office
Parallel Advisors
SBI Securities

View all funds holding Quince Therapeutics